1-Linoleoyl Lysophosphatidic Acid sodium

Description: 1-Linoleoyl lysophosphatidic acid (1-linoleoyl LPA), a glycerophospholipid with linoleic acid at its sn-1 position, acts as an LPA2 receptor agonist and is the predominant LPA form in both mouse and human plasma. This compound preferentially boosts intracellular calcium in Sf9 cells expressing the LPA2 receptor (EC50 = ~10 nM), compared to those with LPA1 and LPA3 receptors (EC50s = ~200 and ~80 nM, respectively). Notably, 1-linoleoyl LPA serum concentrations are elevated in mice with NCTC clone 2472 tumors, while its plasma levels are reduced in primary progressive multiple sclerosis patients-unlike in those with relapsing-remitting multiple sclerosis-and inversely associate with the severity of neurological deficits. Smiles: O=C(CCCCCCC/C=C\C/C=C\CCCCC)OC[C@@H](O)COP(O)(O)=O.[Na]